InSilico Medicine’s $60 Million Series D Financing

Laura Testa Asia & Pacific Legal Chronicle
Tagged:

Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, closed its $60 million Series D financing from…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here